curculigoside has been researched along with Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Guo, Y; Jia, D; Liu, S; Wu, N; Zhao, Y | 1 |
| Han, F; Jiang, W; Kang, Z; Luan, H; Zhu, H | 1 |
2 other study(ies) available for curculigoside and Hypoxia
| Article | Year |
|---|---|
Curculigoside attenuates myocardial ischemia‑reperfusion injury by inhibiting the opening of the mitochondrial permeability transition pore.
Topics: Animals; Apoptosis; Benzoates; Caspase 3; Caspase 9; Cell Survival; Cells, Cultured; Cytochromes c; Glucosides; Hypoxia; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Rats; Rats, Wistar | 2020 |
Curculigoside A induces angiogenesis through VCAM-1/Egr-3/CREB/VEGF signaling pathway.
Topics: Apoptosis; Benzoates; Brain; Caspase 3; Cell Adhesion; Cell Line, Transformed; Cell Movement; Cell Proliferation; CREB-Binding Protein; Dose-Response Relationship, Drug; Endothelial Cells; Ether-A-Go-Go Potassium Channels; Glucose; Glucosides; Humans; Hypoxia; Microvessels; Neovascularization, Pathologic; Signal Transduction; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2014 |